Inventor
HECKER SCOTT J
US44 patents
⚠️ This page may combine multiple inventors who share the name “HECKER SCOTT J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MICROCIDE PHARMACEUTICALS INC
10 patentsUS5989832ANov 23, 1999
Method for screening for non-tetracycline efflux pump inhibitors
MICROCIDE PHARMACEUTICALS INC74 citations94
US5789584AAug 4, 1998
Substituted-pyridinyl cephalosporin antibiotics active against methicillin resistant bacteria
MICROCIDE PHARMACEUTICALS INC18 citations92
US6025352AFeb 15, 2000
Cephalosporin antibiotics
MICROCIDE PHARMACEUTICALS INC19 citations83
US6087355AJul 11, 2000
Cephalosporin antibiotics
MICROCIDE PHARMACEUTICALS INC12 citations73
US5859256AJan 12, 1999
Cephalosporin antibiotics
MICROCIDE PHARMACEUTICALS INC9 citations73
US5593986AJan 14, 1997
Cephalosporin antibiotics
MICROCIDE PHARMACEUTICALS INC5 citations73
US6057312AMay 2, 2000
Cephalosporin antibiotics
MICROCIDE PHARMACEUTICALS INC3 citations62
US6030965AFeb 29, 2000
Cephalosporin antibiotics
MICROCIDE PHARMACEUTICALS INC4 citations62
US5607926AMar 4, 1997
Cephalosporin antibiotics
MICROCIDE PHARMACEUTICALS INC3 citations62
US6066630AMay 23, 2000
Cephalosporin antibiotics
MICROCIDE PHARMACEUTICALS INC0 citations48
METABASIS THERAPEUTICS INC
10 patentsUS9701626B2Jul 11, 2017
Antagonists of the glucagon receptor
METABASIS THERAPEUTICS INC5 citations83
US9169201B2Oct 27, 2015
Antagonists of the glucagon receptor
METABASIS THERAPEUTICS INC8 citations83
US10709718B2Jul 14, 2020
Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof
METABASIS THERAPEUTICS INC1 citations72
US10239829B2Mar 26, 2019
Antagonists of the glucagon receptor
METABASIS THERAPEUTICS INC2 citations72
US10034891B2Jul 31, 2018
Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof
METABASIS THERAPEUTICS INC2 citations72
US10221130B2Mar 5, 2019
Glucagon antagonists
METABASIS THERAPEUTICS INC1 citations71
US9783494B2Oct 10, 2017
Glucagon antagonists
METABASIS THERAPEUTICS INC3 citations71
US11352321B2Jun 7, 2022
Glucagon antagonists
METABASIS THERAPEUTICS INC0 citations61
US9340566B2May 17, 2016
Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof
METABASIS THERAPEUTICS INC2 citations61
US10807946B2Oct 20, 2020
Antagonists of the glucagon receptor
METABASIS THERAPEUTICS INC0 citations51
QPEX BIOPHARMA INC
8 patentsUS11180512B2Nov 23, 2021
Boronic acid derivatives and therapeutic uses thereof
QPEX BIOPHARMA INC4 citations83
US10570159B2Feb 25, 2020
Boronic acid derivatives and therapeutic uses thereof
QPEX BIOPHARMA INC6 citations83
US10294249B2May 21, 2019
Boronic acid derivatives and therapeutic uses thereof
QPEX BIOPHARMA INC8 citations83
US12016868B2Jun 25, 2024
Boronic acid derivatives and therapeutic uses thereof
QPEX BIOPHARMA INC3 citations74
US11999759B2Jun 4, 2024
Boronic acid derivatives and therapeutic uses thereof
QPEX BIOPHARMA INC2 citations72
US11286270B2Mar 29, 2022
Boronic acid derivatives and synthesis thereof
QPEX BIOPHARMA INC3 citations66
US12509475B2Dec 30, 2025
Boronic acid derivatives and therapeutic uses thereof
QPEX BIOPHARMA INC0 citations62
US12552815B2Feb 17, 2026
Boronic acid derivatives and synthesis, polymorphic forms, and therapeutic uses thereof
QPEX BIOPHARMA INC0 citations58
MELINTA SUBSIDIARY CORP
5 patentsUS11090319B2Aug 17, 2021
Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives
MELINTA SUBSIDIARY CORP3 citations83
US12171772B2Dec 24, 2024
Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives
MELINTA SUBSIDIARY CORP0 citations62
US12161656B2Dec 10, 2024
Tetracycline compositions
MELINTA SUBSIDIARY CORP0 citations62
US11684629B2Jun 27, 2023
Therapeutic uses of pharmaceutical compositions comprising cyclic boronic acid ester derivatives
MELINTA SUBSIDIARY CORP0 citations62
US11999757B2Jun 4, 2024
Synthesis of boronate ester derivatives and uses thereof
MELINTA SUBSIDIARY CORP0 citations53